about
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisProfiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.Prognostic impact of lymphocytes in soft tissue sarcomasThe prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomasPrognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomasFibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.Prognostic impacts of hypoxic markers in soft tissue sarcomaCD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survivalThe VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerErratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13].A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer.Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancerStromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung CancerPrognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
P50
Q26797490-08A05AAE-0EF9-4084-A707-281202807A58Q33778580-281B5CE2-779D-4AE7-BC84-E658291B0A3DQ33813250-1A9349F0-BC58-411B-BB4D-4F765A6BFEB0Q33842051-EB848070-AA7D-4702-82CD-040EC7C7992AQ34178633-B847674C-0ADC-4A80-A149-67BE5854279EQ34255022-24E13688-AF4B-49C8-9A99-C57F12FBF81FQ34447850-9F817A98-FF61-4739-9B48-DFD932569841Q34622739-1DBC0449-49CB-4A7E-ABF9-1D0345AA7DAFQ35121634-B0A968EE-5162-4DFD-8CA9-80FC31D8982CQ35645484-6A4D17F3-1B51-400D-B169-A2832C421A35Q35661688-CC8AC1B2-FD0E-45E9-BF8C-10FDBA0BDBCAQ35739745-AACD3C4A-3922-49AC-AC59-9DBDA8742472Q35789146-E88DE223-73B9-4753-AB9D-1759CD1E6561Q36378871-B584B218-2A81-4921-9456-0404B57C90DDQ36898444-D96D73E3-315A-4200-9B48-56429673C4FCQ37502192-8176C114-019C-4B83-8C5B-142CF13805D5Q37687799-F06689EF-6EB1-4D88-8D6E-89F027A70601Q38636708-98E813DE-5E13-4E54-9454-5EC2F5D0090DQ38768015-E4BFC9A5-0F3B-4440-B964-B16FD5BC9504Q42204309-1A540725-42F9-4766-BAA3-C45BA3F8ADF4Q42337044-CD753CFC-91F5-446C-A43A-59082191A936Q42363862-E2F40184-40B1-4F1D-A94A-5F7E258C04A9Q42683596-093527E6-06E9-463F-B010-5A47B4A79801Q47637686-B8976D02-49AC-4B24-8817-32E0D318B612Q49360158-57CA6693-9A69-4E40-89F8-2AA048536BECQ49610619-65F0F7C1-DDF7-4626-BF16-465AC1ACDEEBQ55045737-83C804FD-A097-4F71-87F1-5C5CC3737E33Q57164117-227AAD12-46F3-4BC6-8A20-D68544E7CCFAQ61051591-BC36439A-9F56-431C-85D1-50CC87C51DB8Q61797174-29DB6628-AE17-4FBC-B5A6-E3B554149EB5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas K Kilvaer
@ast
Thomas K Kilvaer
@en
Thomas K Kilvaer
@es
Thomas K Kilvaer
@nl
type
label
Thomas K Kilvaer
@ast
Thomas K Kilvaer
@en
Thomas K Kilvaer
@es
Thomas K Kilvaer
@nl
prefLabel
Thomas K Kilvaer
@ast
Thomas K Kilvaer
@en
Thomas K Kilvaer
@es
Thomas K Kilvaer
@nl
P1015
P214
P1015
P106
P214
P31
P496
0000-0003-1669-0117
P569
1985-01-01T00:00:00Z